References
- Aggernaes H., Kirkegaard C., Krog-Meyer I., et al. Dexamethasone suppression test and TRH test in depression. Acta Psychiatrica Scandinavia 1983; 67: 258–64
- Bowen R. C., Kohout J. The relationship between agoraphobia and primary affective disorders. Canadian Journal of Psychiatry 1979; 24: 317–22
- Carroll B. J. The dexamethasone suppression test for melancholia. British Journal of Psychiatry 1982; 140: 292–304
- Carroll B. J., Feinberg M., Greden J. F., et al. A specific laboratory test for the diagnosis of depression. Archives of General Psychiatry 1981; 38: 15–22
- Carroll B. J., Greden J. F., Haskett R. F., et al. Acta Psychiatrica Scandinavia 1980; 61(supp)183–99
- Coppen A., Abou-Saleh M., Milln P., et al. Dexamethasone suppression test in depression and other psychiatric illness. British Journal of Psychiatry 1983; 142: 498–504
- Crapo L. Cushing's Syndrome: a review of diagnostic tests. Metabolism 1978; 28: 955–77
- Curtis G. C., Cameron O. G., Nesse R. M. The dexamethasone suppression test in panic disorder and agoraphobia. American Journal of Psychiatry 1982; 139: 1043–6
- Evans D. L., Burnett G. B., Nemeroff C. B. The dexamethasone suppression test in the clinical setting. American Journal of Psychiatry 1983; 140: 586–9
- Goggans F. C., Wilson W. R., Gold M. S., et al. Effect of multiple time point sampling on the sensitivity of the dexamethasone suppression test. American Journal of Psychiatry 1983; 140: 909–10
- Gold M. S., Pottash A. C., Extein I., et al. Diagnosis of depression in the 1980s. Journal of the American Medical Association 1981; 245: 1562–4
- Holden N. L. Depression and the Newcastle scale; their relationship to the dexamethasone suppression test. British Journal of Psychiatry 1983; 142: 505–7
- Leckman J. F., Weissman M. M., Merikangas K. R., et al. Panic disorder and major depression. Archives of General Psychiatry 1983; 40: 1055–60
- Lieberman J. A., Brennen R., Lesser M., et al. Dexamethasone suppression test in patients with panic disorder. American Journal of Psychiatry 1983; 40: 917–9
- Marks I. M. Are there anticompulsive or antiphobic drugs? Review of the evidence. British Journal of Psychiatry 1983; 143: 338–47
- Mavissakalian M., Michelson L., Dealy R. S. Pharmacological treatment of agoraphobia: imipramine versus imipramine with programmed practice. British Journal of Psychiatry 1983; 143: 348–55
- Paul S. M., Skonik P. Benzodiazepine receptors and psychopathological states: towards a neurobiology of anxiety. Anxiety: New Research and Changing Concepts, D. F. Klein, J. Rabkin. Raven Press, New York 1981
- Pollitt J., Young J. Anxiety states or masked depression: a study based on the action of monoamine oxidase inhibitors. British Journal of Psychiatry 1971; 119: 143–9
- Robertson H. A., Martin I. L., Landy J. M. Differences in benzodiazepine binding in Mandsley reactive and Mandsley non-reactive rats. European Journal of Pharmacology 1978; 50: 455–7
- Roth M. The phobic anxiety depersonalisation syndrome. Proceedings of the Royal Society of Medicine 1959; 52: 587–95
- Sacher E. J., Hellman L., Roffwarg H. P., et al. Disrupted 24 hour patterns of cortisol secretion. Archives of General Psychiatry 1973; 28: 19–24
- Saleem P. J. Dexamethasone suppression test in depressive illness: its relation to anxiety symptoms. British Journal of Psychiatry 1984; 144: 181–4
- Schapira K., Kerr T. A., Roth M. Phobias and affective illness. British Journal of Psychiatry 1970; 117: 25–32
- Sheehan D. V., Ballenger J., Jacobsen G. Treatment of endogenous anxiety with phobic, hysterical and hypochondriacal symptoms. Archives of General Psychiatry 1980; 37: 51–9
- Sheehan D. V., Claycomb B., Surman O. S., et al. Panic attacks and the dexamethasone suppression test. American Journal of Psychiatry 1983; 140: 1063–4